Insulin resistance compensation: not just a matter of β-cells?

Diabetes

Volumn 63, Issue 3, 2014, Pages 832-834

  Montanya, Eduard ^a,b,c,d  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMANS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE;

EID: 84894462021     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1843     Document Type: Note

References (20)

1. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-794
2. Cnop M, Vidal J, Hull RL, et al. Progressive loss of b-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 2007;30:677-682
3. Brüning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 1997;88:561-572
4. Meier JJ, Butler AE, Saisho Y, et al. b-cell replication is the primary mechanism subserving the postnatal expansion of b-cell mass in humans. Diabetes 2008;57:1584-1594
5. Butler AE, Cao-Minh L, Galasso R, et al. Adaptive changes in pancreatic b cell fractional area and b cell turnover in human pregnancy. Diabetologia 2010;53:2167-2176
6. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102-110
7. Yoon KH, Ko SH, Cho JH, et al. Selective b-cell loss and a-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003;88:2300-2308
8. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic b-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008;10(Suppl. 4):32-42
9. Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA, Butler PC. b-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care 2013;36:111-117
10. Hanley SC, Austin E, Assouline-Thomas B, et al. beta-Cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology 2010;151: 1462-1472
11. Kou K, Saisho Y, Satoh S, Yamada T, Itoh H. Change in b-cell mass in Japanese nondiabetic obese individuals. J Clin Endocrinol Metab 2013;98: 3724-3730
12. Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC. Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care 2006;29:717-718
13. Mezza T, Muscogiuri G, Sorice GP, et al. Insulin resistance alters islet morphology in nondiabetic humans. Diabetes 2014;63: 994-1007
14. Bonner-Weir S, Li W-C, Ouziel-Yahalom L, Guo L, Weir GC, Sharma A. b-Cell growth and regeneration: replication is only part of the story. Diabetes 2010;59:2340-2348
15. Weir GC, Bonner-Weir S. A dominant role for glucose in beta cell compensation of insulin resistance. J Clin Invest 2007;117:81-83
16. Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic b cell proliferation. Cell 2013;153:747-758
17. Thorel F, Népote V, Avril I, et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 2010;464:1149-1154
18. Marchetti P, Lupi R, Bugliani M, et al. A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia 2012;55:3262-3272
19. Talchai C, Xuan S, Lin HV, Sussel L, Accili D. Pancreatic b cell dedifferentiation as a mechanism of diabetic b cell failure. Cell 2012;150:1223-1234
20. Henquin JC, Rahier J. Pancreatic a cell mass in European subjects with type 2 diabetes. Diabetologia 2011;54:1720-1725